Group One Trading’s Apollo Endosurgery, Inc. APEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-1,100
Closed -$10.9K 8500
2023
Q1
$10.9K Hold
1,100
﹤0.01% 5890
2022
Q4
$11K Buy
+1,100
New +$8.2K ﹤0.01% 5989
2022
Q3
Sell
-1,600
Closed -$6K 8535
2022
Q2
$6K Hold
1,600
﹤0.01% 7064
2022
Q1
$10K Buy
+1,600
New +$9.75K ﹤0.01% 7182
2015
Q4
Sell
-104
Closed -$2K 5207
2015
Q3
$2K Sell
104
-112
-52% -$2.13K ﹤0.01% 4702
2015
Q2
$5K Sell
216
-14
-6% -$1.39K ﹤0.01% 4515
2015
Q1
$44K Buy
+230
New +$52.9K ﹤0.01% 3437
2014
Q4
Sell
-10
Closed -$3K 5390
2014
Q3
$3K Hold
10
﹤0.01% 4866
2014
Q2
$3K Hold
10
﹤0.01% 4942
2014
Q1
$4K Buy
+10
New +$3.63K ﹤0.01% 4881

Group One Trading's APEN Position: Q1 2023 in Review

Group One Trading sold out of Apollo Endosurgery, Inc. (APEN) in Q1 2023, closing a stake of 360 shares — an estimated $3.57K sold.

Group One Trading first reported a position in APEN in Q3 2013 and held it in 11 quarters. The position peaked at $29K in Q1 2015. 89 funds tracked by Wall St. Rank hold APEN as of Q1 2023.

  • Group One Trading reported no remaining Apollo Endosurgery, Inc. position as of Q1 2023 after selling out during the quarter.
  • Group One Trading sold 360 Apollo Endosurgery, Inc. shares in Q1 2023, an estimated $3.57K.
  • Group One Trading first reported a position in Apollo Endosurgery, Inc. in Q3 2013 and held it in 11 quarters.
  • Group One Trading's Apollo Endosurgery, Inc. position peaked at $29K in Q1 2015.
  • 89 funds tracked by Wall St. Rank held Apollo Endosurgery, Inc. as of Q1 2023.

Based on Group One Trading's 13F filing for Q1 2023, filed 12 May 2023.